TherapeuticsMD Announces First Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/29/2026
- US stock futures tick higher as tech steadies though oil, yields stay high
- Anthropic prospectus shows $2T IPO ambition, warns of AI 'existential risk'
- Risk appetite remains concentrated in large-cap stocks, Citi says
- Netflix stock: Deutsche Bank gets bullish as valuation leaves room to run
- CarMax shares rise over 2% on strong earnings and revenue beat
TherapeuticsMD (TXMD) Misses Q1 EPS by $1.69
May 16, 2022 4:25 PM EDTTherapeuticsMD (NASDAQ: TXMD) reported Q1 EPS of ($5.69), $1.69 worse than the analyst estimate of ($4.00). Revenue for the quarter came in at $19.3 million versus the consensus estimate of $17.95 million.
For earnings history and earnings-related data on TherapeuticsMD (TXMD) click here.
... More